These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

744 related items for PubMed ID: 19501587

  • 1. Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo.
    Sharma BC, Sharma P, Agrawal A, Sarin SK.
    Gastroenterology; 2009 Sep; 137(3):885-91, 891.e1. PubMed ID: 19501587
    [Abstract] [Full Text] [Related]

  • 2. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.
    Agrawal A, Sharma BC, Sharma P, Sarin SK.
    Am J Gastroenterol; 2012 Jul; 107(7):1043-50. PubMed ID: 22710579
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prevalence of abnormal psychometric tests and critical flicker frequency after clinical recovery of overt hepatic encephalopathy.
    Sharma P, Sharma BC, Sarin SK.
    Neurol India; 2010 Jul; 58(2):220-4. PubMed ID: 20508339
    [Abstract] [Full Text] [Related]

  • 5. An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy.
    Sharma P, Sharma BC, Puri V, Sarin SK.
    Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):506-11. PubMed ID: 18467909
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Critical flicker frequency for diagnosis and assessment of recovery from minimal hepatic encephalopathy in patients with cirrhosis.
    Sharma P, Sharma BC, Sarin SK.
    Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):27-32. PubMed ID: 20133225
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Neuropsychological impairment in severe acute viral hepatitis is due to minimal hepatic encephalopathy.
    Sharma P, Sharma BC, Tyagi P, Kumar M, Sarin SK.
    Liver Int; 2009 Feb; 29(2):260-4. PubMed ID: 18710429
    [Abstract] [Full Text] [Related]

  • 10. Predictors of nonresponse to lactulose in patients with cirrhosis and hepatic encephalopathy.
    Sharma P, Sharma BC, Sarin SK.
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):526-31. PubMed ID: 20009938
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
    Kircheis G, Nilius R, Held C, Berndt H, Buchner M, Görtelmeyer R, Hendricks R, Krüger B, Kuklinski B, Meister H, Otto HJ, Rink C, Rösch W, Stauch S.
    Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
    [Abstract] [Full Text] [Related]

  • 12. Lactulose is highly potential in prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial.
    Wen J, Liu Q, Song J, Tong M, Peng L, Liang H.
    Digestion; 2013 Jun; 87(2):132-8. PubMed ID: 23485720
    [Abstract] [Full Text] [Related]

  • 13. Orthograde whole gut irrigation with mannite versus paromomycine + lactulose as prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial.
    Tromm A, Griga T, Greving I, Hilden H, Hüppe D, Schwegler U, Micklefield GH, May B.
    Hepatogastroenterology; 2000 Jun; 47(32):473-7. PubMed ID: 10791216
    [Abstract] [Full Text] [Related]

  • 14. Prophylaxis of hepatic encephalopathy in acute variceal bleed: a randomized controlled trial of lactulose versus no lactulose.
    Sharma P, Agrawal A, Sharma BC, Sarin SK.
    J Gastroenterol Hepatol; 2011 Jun; 26(6):996-1003. PubMed ID: 21129028
    [Abstract] [Full Text] [Related]

  • 15. Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy.
    Sharma P, Sharma BC, Puri V, Sarin SK.
    J Hepatol; 2007 Jul; 47(1):67-73. PubMed ID: 17459511
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of rifaximin versus lactulose for reducing the recurrence of overt hepatic encephalopathy and hopitalizations in cirrhosis.
    Irimia R, Trifan A.
    Rev Med Chir Soc Med Nat Iasi; 2012 Jul; 116(4):1021-7. PubMed ID: 23700882
    [Abstract] [Full Text] [Related]

  • 17. Can Lactobacillus acidophilus improve minimal hepatic encephalopathy? A neurometabolite study using magnetic resonance spectroscopy.
    Ziada DH, Soliman HH, El Yamany SA, Hamisa MF, Hasan AM.
    Arab J Gastroenterol; 2013 Sep; 14(3):116-22. PubMed ID: 24206740
    [Abstract] [Full Text] [Related]

  • 18. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.
    Mittal VV, Sharma BC, Sharma P, Sarin SK.
    Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):725-32. PubMed ID: 21646910
    [Abstract] [Full Text] [Related]

  • 19. Secondary prophylaxis of hepatic encephalopathy in cirrhosis of liver: a double-blind randomized controlled trial of L-ornithine L-aspartate versus placebo.
    Varakanahalli S, Sharma BC, Srivastava S, Sachdeva S, Dahale AS.
    Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):951-958. PubMed ID: 29727385
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of L-ornithine-L-aspartate as an adjuvant therapy in cirrhotic patients with hepatic encephalopathy.
    Abid S, Jafri W, Mumtaz K, Islam M, Abbas Z, Shah HA, Hamid S.
    J Coll Physicians Surg Pak; 2011 Nov; 21(11):666-71. PubMed ID: 22078345
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.